<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 1: Advanced Phenotyping & Clinical Presentation | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 0 20px 80px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}
.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}
.references-box ol {
 list-style: none;
 padding: 0;
}
.references-box li {
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}
.references-box li::before {
 content: '‚Ä¢';
 position: absolute;
 left: 16px;
 color: #722F37;
 font-weight: 700;
}

@media (max-width: 768px) {
 .lesson-title { font-size: 28px; }
 .module-header-card { padding: 32px 24px; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 20: Assessment Tools | Lesson 1 of 8</span>
 <h1 class="lesson-title">Advanced Phenotyping & Clinical Presentation</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">üíé L2 Advanced Concept</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Credential</div>
 <div class="title">AccrediPro Standards Institute Certified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#beyond-rotterdam"><span class="section-num">01</span>Beyond Rotterdam</a></li>
 <li><a href="#amh-utility"><span class="section-num">02</span>The Utility of AMH</a></li>
 <li><a href="#differential-dx"><span class="section-num">03</span>Differential Diagnosis</a></li>
 <li><a href="#physical-assessment"><span class="section-num">04</span>Physical Assessment Tools</a></li>
 <li><a href="#steady-s"><span class="section-num">05</span>The STEADY Method‚Ñ¢ 'S'</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîÑ</div>
 <div class="connection-text">
 <p>Building on <strong>Module 1: Symptom & Lab Screening</strong>, we now transition from basic diagnostic criteria to <strong>Advanced Phenotyping</strong>. This level of precision allows you to move beyond "general PCOS advice" and offer high-value, individualized metabolic tuning.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Specialist</h3>
 <p>As you advance in your career as a PCOS & Metabolic Health Specialist‚Ñ¢, your ability to distinguish between the subtle nuances of clinical sub-types will be your greatest asset. Many women spend decades feeling "unseen" by conventional medicine because they don't fit the classic stereotype. Today, you learn how to see the invisible drivers of their condition.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the four primary PCOS phenotypes and their unique metabolic risk profiles.</li>
 <li>Evaluate Anti-M√ºllerian Hormone (AMH) as a diagnostic tool for follicle arrest and ovarian reserve.</li>
 <li>Execute a differential diagnosis protocol to distinguish PCOS from NCCAH and HA.</li>
 <li>Apply standardized physical assessment tools including the mFG scale and Acanthosis Nigricans grading.</li>
 <li>Integrate advanced screening data into the 'S' phase of The S.T.E.A.D.Y. Method‚Ñ¢.</li>
 </ul>
 </div>

 <h2 id="beyond-rotterdam">Beyond the Rotterdam Criteria: Identifying Clinical Phenotypes</h2>
 <p>While the 2003 Rotterdam Criteria remain the "gold standard" for diagnosis, they often fail to capture the metabolic reality of the individual. As a specialist, you must look at the <span class="highlight">Phenotype</span>‚Äîthe observable characteristics resulting from the interaction of a client's genotype with their environment.</p>
 
 <p>Current research categorizes PCOS into four distinct phenotypes, each requiring a different clinical focus:</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Phenotype</th>
 <th>Clinical Features</th>
 <th>Primary Metabolic Risk</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Phenotype A (Classic)</strong></td>
 <td>Hyperandrogenism + Ovulatory Dysfunction + Polycystic Ovaries</td>
 <td>Highest risk for Insulin Resistance & Metabolic Syndrome.</td>
 </tr>
 <tr>
 <td><strong>Phenotype B (Hyperandrogenic)</strong></td>
 <td>Hyperandrogenism + Ovulatory Dysfunction (No PCO)</td>
 <td>Significant risk for Type 2 Diabetes and Cardiovascular disease.</td>
 </tr>
 <tr>
 <td><strong>Phenotype C (Ovulatory)</strong></td>
 <td>Hyperandrogenism + Polycystic Ovaries (Regular cycles)</td>
 <td>Often overlooked; mild IR but high risk for androgenic hair loss/acne.</td>
 </tr>
 <tr>
 <td><strong>Phenotype D (Non-Androgenic)</strong></td>
 <td>Ovulatory Dysfunction + Polycystic Ovaries (Normal Androgens)</td>
 <td>Often "Lean PCOS"; primary driver is frequently HPA-axis or Inflammatory.</td>
 </tr>
 </tbody>
 </table>

 <h3>The "Lean PCOS" Nuance</h3>
 <p>Phenotype D and some cases of Phenotype C often present as <span class="highlight">Lean PCOS</span>. These clients typically have a BMI under 25, yet they may still suffer from "skinny fat" syndrome (sarcopenic obesity). In these cases, the assessment must focus on <strong>visceral adiposity</strong> and <strong>post-prandial glucose spikes</strong> rather than fasting insulin alone.</p>

 <div class="coach-tip">
 <span class="tip-label">Specialist Insight</span>
 <p>When working with Lean PCOS clients, avoid the standard "weight loss" narrative. Instead, focus your marketing and coaching on <strong>"Metabolic Optimization"</strong> and <strong>"Muscle as Medicine."</strong> This shift in language builds immediate trust with women who have been told by doctors to "just lose weight" despite already being at a low body weight.</p>
 </div>

 <h2 id="amh-utility">Anti-M√ºllerian Hormone (AMH): The Marker of Follicle Arrest</h2>
 <p>In conventional fertility settings, AMH is used to measure "ovarian reserve." However, in the context of PCOS assessment, we use it to measure the <strong>severity of follicle arrest</strong>. AMH is produced by the granulosa cells of small, antral follicles.</p>

 <p>In women with PCOS, AMH levels are typically <span class="highlight">2 to 4 times higher</span> than in healthy controls. This is not necessarily a sign of "more eggs," but rather a sign that the follicles are "stuck" in the pre-antral stage, unable to progress to ovulation due to high local androgen levels and hyperinsulinemia.</p>

 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üìã</div>
 <div>
 <p class="title">Case Study: Sarah, 44</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <p><strong>Profile:</strong> Former teacher, now health coach student. BMI 22. Struggling with secondary infertility and "brain fog."</p>
 <p><strong>The Challenge:</strong> Sarah was told she was "too thin" for PCOS and "too old" for high fertility. Her AMH came back at 7.2 ng/mL (unusually high for age 44).</p>
 <p><strong>Intervention:</strong> Using the STEADY Method‚Ñ¢, the specialist identified Sarah as Phenotype D. The high AMH confirmed follicle arrest driven by subclinical inflammation, not "age-related decline."</p>
 <p><strong>Outcome:</strong> By addressing the 'D' (Detox/Inflammation) and 'T' (Glucose Tuning), Sarah restored ovulation within 4 months. Specialists mastering this level of assessment can easily command $250+ per consultation.</p>
 </div>
 </div>
 </div>

 <h2 id="differential-dx">Differential Diagnosis: Distinguishing PCOS from Mimics</h2>
 <p>A critical step in advanced assessment is the <strong>Rule-Out Protocol</strong>. PCOS is a diagnosis of exclusion. You must ensure the client isn't actually suffering from a condition that mimics PCOS symptoms but requires different management.</p>

 <ul>
 <li><strong>Non-Classic Congenital Adrenal Hyperplasia (NCCAH):</strong> A genetic condition where the adrenal glands overproduce androgens. It looks identical to PCOS Phenotype A or B. <em>Key Marker: 17-Hydroxyprogesterone (17-OHP).</em></li>
 <li><strong>Hypothalamic Amenorrhea (HA):</strong> Often occurs in "lean" women due to over-exercise or under-eating. Cycles stop, and ovaries may look "polycystic" on ultrasound due to lack of stimulation. <em>Key Marker: Low LH and Low Estrogen.</em></li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Specialist Tip</span>
 <p>If a client has a very low LH (under 2.0) and high stress/low calorie intake, suspect HA over PCOS. Applying PCOS-style "carb restriction" to an HA client can be metabolically disastrous. Always screen for energy availability!</p>
 </div>

 <h2 id="physical-assessment">Standardized Physical Assessment Tools</h2>
 <p>Objective data isn't just in the bloodwork; it's in the physical presentation. You should train your eye to use these two standardized tools:</p>

 <h3>1. The Modified Ferriman-Gallwey (mFG) Scale</h3>
 <p>This tool assesses hirsutism (excess hair growth) in 9 androgen-sensitive areas. A score of <strong>&gt;4-6</strong> (depending on ethnicity) indicates clinical hyperandrogenism. Tracking this score every 3-6 months provides objective proof that your 'E' (Endocrine Alignment) strategies are working.</p>

 <h3>2. Acanthosis Nigricans (AN) Grading</h3>
 <p>AN is a velvety, hyperpigmented skin change typically found on the back of the neck, armpits, or groin. It is a <strong>direct physical manifestation of severe insulin resistance</strong>. High levels of insulin cross-react with IGF-1 receptors in the skin, causing rapid cell growth.</p>

 <div class="coach-tip">
 <span class="tip-label">Client Communication</span>
 <p>When you see AN, explain it to the client as a "metabolic dashboard light." Instead of making them feel self-conscious, frame it as: "Your skin is giving us a real-time update on your insulin levels. As we tune your glucose, we'll watch this light dim."</p>
 </div>

 <h2 id="steady-s">Utilizing the STEADY Method‚Ñ¢ 'S' (Symptom Screening)</h2>
 <p>The 'S' in The S.T.E.A.D.Y. Method‚Ñ¢ stands for <strong>Symptom & Lab Screening</strong>. At the L2 level, this isn't just a checklist‚Äîit's <strong>Mapping</strong>. You are looking for the "Metabolic Fingerprint."</p>

 <p>When conducting your initial assessment, map the following correlations:</p>
 <ul>
 <li><strong>Androgen Signs + Hair Loss:</strong> Focus on 5-alpha reductase activity (Endocrine Alignment).</li>
 <li><strong>Irregular Cycles + High Stress:</strong> Focus on the HPA-axis and Cortisol (Endocrine Alignment).</li>
 <li><strong>Skin Tags + AN + Fatigue:</strong> Focus on the Insulin-Androgen Axis (Glucose Tuning).</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Income Potential</span>
 <p>Health coaches who provide this level of clinical mapping often transition from $75/hour sessions to $3,000+ 12-week "Metabolic Reset" packages. Your value is no longer your time; it is your <strong>diagnostic precision</strong>.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Which phenotype is often referred to as "Non-Androgenic PCOS" and may present in leaner individuals?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Phenotype D. This phenotype presents with ovulatory dysfunction and polycystic ovaries, but normal circulating androgen levels.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What does a high AMH level (e.g., &gt;5 ng/mL) typically signify in a suspected PCOS client?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It signifies follicle arrest. The ovaries have many small follicles producing AMH, but they are unable to mature and ovulate due to hormonal imbalances.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Which lab marker is essential to rule out Non-Classic Congenital Adrenal Hyperplasia (NCCAH)?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">17-Hydroxyprogesterone (17-OHP). High levels of this precursor indicate an enzymatic block in the adrenal glands rather than primary PCOS.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. True or False: Acanthosis Nigricans is caused by poor hygiene.</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">False. It is a metabolic skin condition caused by hyperinsulinemia stimulating keratinocytes and fibroblasts.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <span class="box-label">Key Takeaways</span>
 <ul>
 <li><strong>Phenotyping is Precision:</strong> Moving beyond the general diagnosis to identify the specific sub-type (A, B, C, or D) dictates the metabolic priority.</li>
 <li><strong>AMH as a Severity Marker:</strong> Use AMH to gauge the degree of follicle arrest and track progress in restoring ovarian communication.</li>
 <li><strong>Rule-Outs are Non-Negotiable:</strong> Always screen for NCCAH and HA to avoid misapplying PCOS protocols to "mimic" conditions.</li>
 <li><strong>Physical Markers tell the Story:</strong> The mFG scale and AN grading provide objective, low-cost ways to track insulin and androgen improvements.</li>
 <li><strong>The Specialist Advantage:</strong> Your ability to interpret these nuances is what allows you to charge premium rates and achieve superior client outcomes.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <span class="box-label">References & Further Reading</span>
 <ol>
 <li>Teede, H. J., et al. (2023). "Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome." <em>The Lancet Diabetes & Endocrinology.</em></li>
 <li>Barber, T. M., & Franks, S. (2021). "Obesity and Polycystic Ovary Syndrome." <em>Clinical Endocrinology.</em></li>
 <li>Lizneva, D., et al. (2016). "Phenotypes of Polycystic Ovary Syndrome." <em>Fertility and Sterility.</em></li>
 <li>Dumont, A., et al. (2015). "Role of Anti-M√ºllerian Hormone in Pathophysiology, Diagnosis and Treatment of Polycystic Ovary Syndrome." <em>Human Reproduction Update.</em></li>
 <li>Witchel, S. F., et al. (2019). "The Diagnosis of Polycystic Ovary Syndrome during Adolescence." <em>Hormone Research in Paediatrics.</em></li>
 <li>Yildiz, B. O., et al. (2010). "Visually scoring hirsutism: a comparison of standard and modified Ferriman-Gallwey methods." <em>European Journal of Endocrinology.</em></li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 const isVisible = answer.style.display === 'block';
 answer.style.display = isVisible ? 'none' : 'block';
 this.textContent = isVisible ? 'Reveal Answer' : 'Hide Answer';
 }
 });
 });
</script>

</body>
</html>